Effects of Poly-MVA on the rheological properties of blood after in-vivo exposure to gamma radiation  by El-Marakby, Seham M. et al.
ww.sciencedirect.com
j o u rn a l o f r a d i a t i o n r e s e a r c h and a p p l i e d s c i e n c e s 6 ( 2 0 1 3 ) 2 1e3 0Available online at wScienceDirect
journal homepage: ht tp: / /www.elsevier .com/locate/ j r rasEffects of Poly-MVA on the rheological properties of blood
after in-vivo exposure to gamma radiationSeham M. El-Marakby a, Nabila S. Selim a, Omar S. Desouky a,*, Hoda A. Ashry a,
Abdelsattar M. Sallam b
aBiophys. Lab, Rad. Phys. Depart. National Center for Radiation Research and Technology (NCRRT), AEA, P.O. Box 29, Madinat Nasr, Cairo,
Egypt
b Phys. Dep., Faculty of science, Ain Shams University, Cairo, Egypta r t i c l e i n f o
Article history:
Received 4 July 2013
Accepted 25 September 2013
Keywords:
Red blood cells
Gamma radiation
Rheological properties
Poly-MVA
Radio-prophylaxis effects* Corresponding author.
E-mail address: omardesouky@yahoo.com
Peer review under responsibility of The Egy
Production and hosting by El
1687-8507/$e see frontmatterCopyrightª 2013,TheEg
http://dx.doi.org/10.1016/j.jrras.2013.10.002a b s t r a c t
This study aims to examine the radio-prophylactic effects of poly-MVA against expo-
sure to acute dose of gamma radiation. Adult male rats, weighing 200 gm, were exposed
to 6 Gy gamma radiation from Cs-137 source. The animals received daily oral admin-
istration of 2 ml/kg body weight of poly-MVA for different time intervals. The pro-
phylactic effect was examined by two modes of administration: two weeks before
irradiation and another group which received continuous administration for two weeks
before and two other weeks after irradiation (total time of administration 28 days).
Different parameters were performed, which include determination of cellular anti-
oxidant enzymes (Glutathione (GSH), catalase and superoxide dismutase) in hepatic
cells, the rheological properties of blood, osmotic fragility and scanning electron mi-
croscope photography of red blood cells. Exposure to radiation resulted in a significant
decrease in cellular antioxidant enzymes (GSH, Catalase and SOD) and decrease in
Bingham viscosity, yield stress and aggregation index of blood. Furthermore it induced
slightly increase in average osmotic fragility of red blood cells accompanied by decrease
in osmotic dispersion and remarkable modification of red blood cell morphology.
Administration of Poly-MVA showed markedly elevation in GSH, Catalase and SOD
content in liver cells in all treated groups. It also showed improvement in all observed
parameters. The obtained results showed that oral uptake of poly MVA posses a radio-
prophylactic effect that might be used in planned radiation exposure in diagnosis and
radiotherapy.
Copyright ª 2013, The Egyptian Society of Radiation Sciences and Applications. Production
and hosting by Elsevier B.V. All rights reserved.(O.S. Desouky).
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Development of agents for prophylaxis, mitigation and treat-
ment of radiation injury is an important task for radiological
studies. Radio-prophylactics are agents that must be given
before radiation exposure; to minimize the effect of radiation
(Stone, Moulder, & Coleman, 2004).Many research works are
directed towards finding effective agents that would suc-
cessfully prevent the development of radiation syndrome and
protect biological system from free radicals that appear as a
consequence of the exposure to radiation. Many compounds,
that had been considered potential chemical radioprotectors,
have been tested. Only some of them have shown to have
significant effects. Among the investigated compounds
certain number of them, under specific circumstances, has
shown a considerably protective effect in the experiments
with the animals (Citrin et al., 2010; Greenberger, 2009;
Hosseinimehr, 2007; Jagetia, 2007; Madhu & Kumari, 2014;
Maurya Dharmendra, Devasagayam Thomas, & Krishnan
Cherupally, 2006; Nair, Parida, & Nomura, 2001; Peebles,
Soref, Copp, Thunberg, & Fahl, 2012; Shukla & Gupta, 2010;
Weiss, 1997; Yamini & Gopal, 2010). Synthetic thiol Amifos-
tine (Ethyol) is the only FDA approved radioprotective treat-
ment available today (Cassatt, Fazenbaker, Bachy, & Hanson,
2002). However, it has significant shortcomings including
relatively high toxicity, unfavorable routes of administration,
and narrow protection time window (Hosseinimehr, 2007).
Because of its adverse side effects (nausea, vomiting and hy-
potension) in humans, effectiveness of Amifostine in clinical
trials is significantly diminished compared to that in animal
studies (Weiss & Landauer, 2003).
However, there is a need for solving the problems con-
cerning the unwanted effects and to find pharmaceutical
formulation of radioprotectors for oral application. Palladium
a-lipoic acid complex (PLAC) was formulated to act as a non-
toxic chemotherapeutic agent for oral administration. It ex-
ists in a prescription version called DNA Reductase, and
available commercially as dietary supplement called poly-
MVA (Antonawich, Fiore, & Welicky, 2004).The active ingre-
dient in this complex is the palladiumelipoic acid polymer,
which exists as a trimer of palladiumelipoic acid joined to
thiamine in an arrangement which allows it to be both water
and lipid soluble, and the initials “MVA” stand for minerals,
vitamins, and amino acids (Garnett, 1995). Palladium, which is
a transition mineral, serves as highly efficient aerobic catalyst
(Stahl, 2005). During oral administration of this material in the
emergency treatment of certain brain tumors, it was found
that patients receiving concurrent radiation did not develop
the usual signs of radiation toxicity such as nausea, exhaus-
tion, disorientation, and depression (Garnett and Remo, 2001).
It was examined for its efficacy as a radioprotector; it signifi-
cantly reduced the g-radiation-induced mortality in mice and
aided recovery from the radiation-induced loss of bodyweight
after 8 Gy exposures. Also, the radiation-inducedDNAdamage
in these cells was reduced when PLAC was administered to
animals exposed to a lethal dose of 8 Gy whole-body gamma-
radiation (Ramachandran, Krishnan, & Nair, 2010). Adminis-
tration of poly-MVA, for seven days prior to whole body
gamma radiation significantly reduced the damage to cellularDNA in bone marrow and blood leukocytes, as well as pre-
venting the radiation-induced lowering of tissue antioxidant
levels (Menon, Krishnan, & Nair, 2009). Toxicological studies
indicated that the LD50 of poly-MVA exceeded 5000mg/kg, and
no mutagenic effect of the combination was observed in the
Ames test (Bunger, Stork, & Stalder, 1996).
As lipoic acid is apowerful antioxidant that iswater and fat-
soluble, it allows the Poly-MVA to penetrate the cell mem-
branes and the blood brain barrier. Since it is a polymer (liquid
crystal), rather than a single molecule, this liquid crystalline
structure allows it to store a great deal of energy and thus serve
as a semiconductor (Garnett and Garnett, 1996). Therefore,
LAPC is not only a potent free radical scavenger, but it also
provides cellular energy. It acts as a liquid electrical transistor
that transfers electrical current from the cell membrane to the
mitochondria which redistributes the electrical current
throughout the cell via the existing electrical pathways
(Garnett and Garnett, 1996). It oscillates between an oxidized
and reduced formas it accepts unpaired electrons anddonates
them to its enzymatic site. In cancer cells, it has been demon-
strated to be an oxidizer of membrane fatty acids, serving as a
redox shunt to provide a continuous river of reducing equiva-
lents to protect DNA against oxidation (Garnett, 2002).
In this study, the efficiency of poly MVAwas examined as a
radio-prophylactic agent against exposure to a single suble-
thal dose of gamma radiation.2. Materials and methods
2.1. Chemicals
Poly-MVA is a liquid dietary supplement that contains 23.5mg/
ml of lipoic acidepalladium complexes as well as minerals
(molybdenum, rhodium, ruthenium), vitamins (B1, B2 and B12),
and amino acids (N-acetyl cysteine and formyl methionine).
The palladium lipoic acid formulation, used in this study, was
obtained as a gift from Garnett McKeen Laboratory, Inc., USA.
2.2. Animals
Adult male Swiss Albino rats weighing 200 g were used.
They were divided into 4 groups of 18 animals each: control
group, treated group with poly-MVA, irradiated group and
treated-irradiated group. Rats were kept under standard
conditions along the experimental period. Food and water
were supplied daily ad libitum. All animals were housed ac-
cording to the ethical rules in compliance with institutional
guidelines. The conditions were the same for all animals
throughout the study. The animals were housed in standard
cages (26  42  15 cm) with sawdust, at constant room
temperature (25  1 C) and relative humidity (45e55%) with a
12 h light/dark cycle. They were dissected at three times in-
tervals: 1, 7, 14 days after exposure to radiation.
2.3. Irradiation
Animals were placed in a specially designed well-ventilated
acrylic pie cage which holds up to 20 rats. The whole body of
the animals was exposed to 6 Gy gamma radiation from the
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Fig. 1 e Blood flow curve for control group.
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dose rate: 0.769 cGy/s (manufactured at the atomic energy
agency, Canada) at the National Center for Radiation Research
and Technology, Cairo. The dose rate was calibrated at the
beginningof the experimentalworkby the EgyptianHigh-Dose
Reference Laboratory. The animals were exposed to 6 Gy acute
dose. The activity of the irradiation source allows the animals
to receive the recommended dose in this study in 13 min.
2.4. Treatment
Poly-MVA was taken orally with daily dose of 2 ml/kg body
weight. Rats were divided into (4) main groups:
1. Normal control group: it consisted of six rats, kept un-
irradiated and un-treated as normal control group.
2. Irradiated group (group A): it includes 3 subgroups accord-
ing to the dissection time: 1, 7, 14 days after irradiation.
Each irradiated group of rats was composed of 6 rats.
3. The radio-prophylactic effect of poly-MVA was evaluated
after two modes of administration:
a) Uptake of poly-MVA before irradiation (Group B), it
consisted of two subgroups treated with poly-MVA for
two consecutive weeks; one of the subgroups was
exposed to radiation at the end of administration
period. Themeasurements were performed 1 day after
stopping administration and/or irradiation, and
continued to the 7th and 14th days. The other was kept
un-irradiated as positive control, administration of
poly-MVA was stopped after two weeks then the
measurements were performed at 1, 7, 14 days.
b) Continuous administration of poly-MVA before and
after irradiation (Group C), it consisted of two sub-
groups: one subgroup treated with poly-MVA for two
consecutive weeks before irradiation and the admin-
istration continued for two other weeks. The mea-
surements were performed 1 day after irradiation, and
continued at the 7th and 14th days during poly-MVA
administration. The other subgroup received admin-
istration of poly-MVA for four consecutive weeks (total
time of administration 28 days). The measurements
started after two weeks of administration (at the 14th
day) and continued to the 21st and 28th days.
2.5. Preparation of samples
Animals were anesthetized by exposure to diethyl ether in a
closed container by open-drop method. The blood samples
were withdrawn from the left ventricle of the heart using
heparinized needles. After dissection, the liver washed with
isotonic 0.9% NaCl. 10% of liver sample in saline was homog-
enized using a Tri-R STIR-Rmodel K41 homogenizer, and then
the homogenate was centrifuged at 3000 rpm for 10 min at
4 C. The supernatant was separated for use in analysis.
2.6. Determination of antioxidants enzymes
2.6.1. Glutathione (GSH) assay
The hepatic level of glutathione (GSH) was measured spec-
trophotometrically using Ellman’s reagent with 5-50, dithiobis-2-nitrobenzoic acid [DTNB] as a coloring reagent, according to
the method of (Beutler, 1963). The absorbance was read at
412 nm using a UVeVIS spectrophotometer CECIL-3041.
2.6.2. Catalase estimation
The catalase activity was measured in liver cells by catalytic
reduction of hydrogen peroxide using the method of Sinha
(1972).
2.6.3. Superoxide dismutase (SOD)
Superoxide dismutase activity can easily be measured by
using the method of Minami and Yoshikawa (1979).
2.7. Rheological properties of blood
The rheological properties were measured by means of
Brookfield DV-III Programmable Rheometer. It is a cone-plate
viscometer that measures fluid parameters of shear stress
and viscosity at given shear rates. The body temperature
varies from 29 C at the surface to 37 C in the blood stream.
Red blood cells (RBCs) properties are well known to be
temperature-dependent, so that statistically significant dif-
ferences were present in a wider range of temperatures be-
tween 25 and 37 C (Baskurt & Mat, 2000). In this study, the
temperature was set at 35 C. The applied shear rate was
7.5e375 s1. The data was collected from the rheometer by
means of software program “Rheocalc for Windows”. The
change in viscosity with shear rate gives the flow curve (Fig. 1),
which is characterized by two regions: in the low shear rate up
to 100 s1, and high shear region; from 100 s1 up to the shear
rate at which no change in viscosity is obtained.
For analysis of the flow curve, the Bingham plastic model
was applied to calculate the yield stress (F0) and viscosity (h) as
follows:
F ¼ F0 þ hD
where F is the shear stress (dyne/cm2) and D is the shear
rate (s1).
Since the blood viscosity at low shear rate is greatly
affected by the RBCs aggregation, the ratio of viscosities at 20
and 100 s1 can be regarded as quantitative characteristic of
RBCs aggregation efficiency (Aggregation index) (Dobrovol’skii
et al., 1997).
j o u r n a l o f r a d i a t i o n r e s e a r c h and a p p l i e d s c i e n c e s 6 ( 2 0 1 3 ) 2 1e3 024Aggregation index ¼ hat20s1
hat100s1
2.8. Osmotic fragility measurements
The process of osmosis was studied by placing red blood cells
(RBCs) in solutions of different tonicity. The osmotic lysis of
RBCs is easily detected by the release of hemoglobin (Hb) into
the extracellular fluid. The amount of Hb appearing in media
of different ionic strength was determined spectrophotomet-
rically at 540 nm to characterize the degree of hemolysis ac-
cording to themethod reported by Dacie and Lewis (2006). The
quantitative measurements (degree of hemolysis versus
decreasing NaCl concentration) are plotted on a graph called
the fragility curve as shown in Fig. 2 (Mazeron, Didelon,
Muller, & Stoltz, 2000). The experimental curves were
normalized to 100% hemolysis to facilitate the comparison
between different samples without the interference of the
hematocrit changes. The fragility curve can be evaluated by
the following parameters:
1 Average osmotic fragility (H50): the NaCl concentration
producing 50% homolysis.
2 Dispersion of hemolysis (S): it is defined as the difference
between the maximum and minimum values of NaCl
concentration at which the rate of hemolysis (dH/dC) ¼ 0.
High values of S correspond to isohemolysis (homogenous
RBCs population), and low values of S to anisohemolysis
(heterogenous RBCs population) (Kergounou, Thiriot,
Braquet, Ducousso, & Rocquet, 1986).2.9. Morphological analysis
The morphology of RBCs was studied using scanning electron
microscope (SEM) according to Ross, Wang, and Jelinek (2007)
as follows: Three drops of RBCs suspension were added
directly to 5 ml of 2.5% glutaraldehyde in 0.1 M cacodylate
buffer, pH 7.4. Fixation was allowed to proceed for at least 1
day before processing. The cells were washed twice in caco-
dylate buffer, dehydrated with two washes in 70% ethanol,
washed twice in 95% ethanol, twice in absolute ethanol and
twice in acetone. One drop of the cell suspension was applied
to an acetone-washed coverslip and allowed to dry. The
coverslip was fixed to an aluminum stub using a colloidal
silver adhesive and gold coated using a sputter coater (SPI).
Electron microscopy was carried out using a Jeol Model JSM-0
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Fig. 2 e Fragility curve of RBCs.5400 scanning electron microscope at the National Center
for Radiation Research and Technology (NCRRT).
2.10. Statistical analysis
In this study, the values are expressed as mean values  -
standard deviation. The significance of the difference between
the values of the treated groups and control was evaluated by
the Student t-test and values with p < 0.05 were considered as
statistically significant (Snedecor & Cochran, 1989).3. Results
The radio-prophylactic effect of poly MVA against exposure to
acute dose of gamma radiation (6 Gy) was studied by its daily
administration for two weeks before exposure to gamma ra-
diation for two different groups. In the first group the
administration of poly MVA was stopped after irradiation
(group B) and the second group the administration continued
after irradiation for two more weeks (group C).
A significant decrease in cellular antioxidant enzymes
(GSH, Catalase and SOD) was shown in irradiated animals
(group A) compared to control group, and it is more noticeable
at 14th day after exposure (Table 1). Also radiation exposure
resulted in significant decrease in Bingham viscosity, yield
stress and aggregation index of blood, which persist until 14th
day as shown in Fig. 3. Furthermore it induced slightly in-
crease in average osmotic fragility of red blood cells (Fig. 4)
accompanied by decrease in osmotic dispersion S after 1 day
of exposure then the dispersion non-significantly increased at
7th and 14th day.
Uptake of poly-MVA showed non-significant change in
glutathione content with elevation in cellular catalase and
SOD enzymes activity (Table 1), while it produced a significant
decrease in blood Bingham viscosity and yield stress with a
non significant change in aggregation index, accompanied by
a significant increase in average osmotic hemolysis and os-
motic dispersion which continued increasing with time of
poly-MVA administration (Figs. 3 and 4).
Poly-MVA raised the concentration of antioxidant enzymes
in liver cells in both treated groups (B and C) as shown in Table
1. In group B, administration of Poly-MVA resulted in slightly
decrease in Bingham viscosity, yield stress and aggregation
index compared to control group, reducing the damage
induced by radiation exposure. While it showed a significant
decrease in osmotic dispersion with non-significant change in
mean osmotic fragility H50.
Continuous administration of Poly-MVA before and after
irradiation (Group C) shows significant decrease in Bingham
viscosity, yield stress and aggregation index at 1, 7 days after
radiation exposure, while at 14th day their values were close to
control value. Furthermore, it showed a significant increase in
H50 and non-significant change in osmotic dispersion.
The changes in RBCs shape was investigated by scanning
electron microscope (SEM). Figs. 5 and 6 shows scanning
electron micrographs of RBCs samples of control, irradiated
and the treated groups with Poly-MVA (B and C), at different
time intervals (1, 7 and 14 days), prepared immediately after
withdrawal. It shows the normal biconcave shape (a) of a
Table 1 e The antioxidants content (Glutathione m/g tissue, Catalase U/g tissue and Superoxide dismutase enzymes U/g
tissue) in control, treated, irradiated and treated-irradiated groups at different time intervals (1, 7 and 14 days).
Treatment with poly MVA Groups Statistics GSH content Catalase activity SOD activity
1 day 7 days 14 days 1 day 7 days 14 days 1 day 7 days 14 days
Without treatment Control Mean 14.72 14.72 14.72 1.27 1.27 1.27 35.67 35.67 35.67
S. D. 1.19 1.19 1.19 0.29 0.29 0.29 8.73 8.73 8.73
6 Gy Mean 13.48* 12.99* 12.96* 1.40 1.05 1.03 28.74 19.67* 8.69*
S. D. 0.96 0.38 0.53 0.39 0.17 0.11 5.86 2.76 1.90
Before irradiation (group B) Poly-MVA Mean 15.62 14.80 14.07 2.00 2.27* 2.61 49.69* 57.87* 56.38*
S. D. 3.14 1.56 2.02 0.30 0.21 0.69 0.86 5.91 4.87
6 Gy þ Poly-MVA Mean 14.12 15.56 13.86 2.04* 1.91* 1.93* 48.92* 47.61* 44.21
S. D. 1.39 2.22 1.25 0.26 0.33 0.11 9.31 8.77 4.02
Continuous treatment (group C) Poly-MVA Mean 14.05 14.17 15.29 2.17* 2.36* 2.25* 56.22* 61.25* 69.61*
S. D. 0.69 0.47 0.64 0.59 0.03 0.35 7.49 0.81 2.73
6 Gy þ Poly-MVA Mean 13.81 14.12 14.43 1.65* 1.43 1.66 36.10 38.94 48.00*
S. D. 0.66 0.22 0.22 0.15 0.28 0.26 9.18 5.98 4.10
S.D.: standard deviation.
*: statistically significant.
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Fig. 3 e The Bingham viscosity, Yield stress and Aggregation index of control, irradiated and treated groups with poly-MVA,
(B) group B (administrated before irradiation) and (C) group C (continuous administration), at different time intervals (1, 7
and 14 days).
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Fig. 4 e The dispersion of hemolysis and average osmotic fragility of control, irradiated and treated groups with poly-MVA,
(B) group B (administrated before irradiation) and (C) group C (continuous administration), at different time intervals (1, 7
and 14 days).
j o u r n a l o f r a d i a t i o n r e s e a r c h and a p p l i e d s c i e n c e s 6 ( 2 0 1 3 ) 2 1e3 026control. A remarkable modification of red blood cell
morphology with distinct echinocyte and stomatocytes for-
mationwas observed in irradiated groups as shown in (b). Oral
uptake of Poly-MVA diminishes the formation of abnormal
shapes, reducing the radiation induced damage in all groups
(B and C) as shown in figures (d). Scanning electron micro-
graphs showed that continuous administration of poly-MVA
resulted in a better radio-prophylactic effect.4. Discussion
Red blood cells (RBCs) constitute 99% of blood cellular com-
ponents, so they govern its rheological properties (Pal, 2003).
The RBC membrane consists of the phospholipid bilayer
containing integral membrane proteins and the underlying
membrane cytoskeleton (Svetina, Kuzman, Richard, Ziherl, &
Zeks, 2004). Blood rheology is altered in various conditions:
Changes at the level of hematocrit notably lead to variations
in hemorheological parameters. Also modifications of the
membrane skeletal proteins, the ratio of RBC membrane sur-
face area to cell volume, cell morphology, and cytoplasmic
viscosity influence deformability of RBCs. Also, RBC aggrega-
tion is mainly determined by plasma protein composition and
surface properties of RBCs (Baskurt & Meiselman, 2003). Red
cell rheological abnormalities due to alterations of these fac-
tors can thus be expected to lead to both disturbances of themicrocirculation and also to changes of red cell survival
in vivo. In the present study exposure to 6 Gy acute dose
causes decrease in Bingham viscosity accompanied by in-
crease in average osmotic fragility that is might be due to the
oxidative changes occurred in cell membrane as a result of
radiation exposure. Previous studies showed that cell mem-
branes are particularly sensitive to the effects of radiation-
induced oxidative damage and that lipid peroxidation which
can alter membrane structure and function (Schroeder, 1984).
In addition, numerous experiments have suggested that ra-
diation may modify the transport mechanisms, react with
membrane-bound proteins (Stark, 1991). Importantly, several
membrane biophysical parameters may also be altered by
radiation induced oxidative stress (e.g., shape, permeability,
and osmotic fragility) (Joseph et al., 2000).
Scanning electron micrographs showed distinct de-
formations in RBCs membrane as a result of radiation expo-
sure. Free radicals generated during radiation result in
destructive processes within both layers of RBCs membrane
lipids (Shadyro et al., 2002) and structural changes in the RBCs
membrane proteins and a decrease in its intramolecular dy-
namics (Dreval, Sichevskaia, Doroshenko, & Roshal, 2000).
Conformational change of integral membrane proteins could
lead to an expansion of one leaflets of the membrane double
layer relative to the other one and in turn results in a shape
change (Gimsa & Ried, 1995). Poly-MVA reduced the radiation
induced deformation in RBCs membrane.
Fig. 5 e The scanning electromicrogragh of RBCs of control (a), irradiated (b), treated with Poly-MVA (c) and treated with
irradiation (d) of the first mode of administration of poly-MVA (Group B) at different time intervals (1, 7 and 14 days).
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(Garnett and Garnett, 1996). The interaction of polymer
nanoparticles with biological membranes is a complex pro-
cess due to the heterogeneity of both the nanoparticles and
the cell membranes (Leroueil et al., 2007). Recent studies
indicated that nanoparticles can strongly interact with cell
membranes, either by adsorbing onto the membrane or
compromising its integrity (Binder, Sachsenhofer, Farnik, &
Blaas, 2007; Li, Chen, & Gu, 2008). Li et al., 2008 reported
that a hydrophobic nanoparticle can result in the inclusion
into the bilayer, whereas a semihydrophilic nanoparticle is
only found to adsorb into the membrane. Also, the defor-
mation of the lipid bilayer induced by the addition of nano-
particles is short-range, and the rearrangement of lipid
molecules plays a significant role for morphological varia-
tions of nanopaticles-containing lipid membrane. Beingsoluble in water and lipid, poly-MVA can be found in both cell
membrane and cytosol. Adhesive interactions due to elec-
trostatic forces, van der Waals, or steric interactions are
suspected to be involved in these processes (Rothen-
Rutishauser, Schu¨rch, & Gehr, 2007). The entering mecha-
nism of nanoparticles into RBCs is different from phagocy-
tosis and endocytosis, since they have neither phagocytic
receptors on their surface nor the structures necessary for
phagocytosis. It may occur by unspecific means, including
diffusion, trans-membrane channels, and electrostatic, van
der Waals, hydration forces, or adhesive interactions
(Rothen-Rutishauser, Schu¨rch, Haenni, Kapp, & Gehr, 2006).
Although oral uptake of Poly-MVA minimizes the radiation
effect it resulted in obvious changes in blood Bingham vis-
cosity and average osmotic hemolysis as a result of the
interaction of the nano-complex with cell membrane.
Fig. 6 e The scanning electromicrogragh of RBCs of control (a), irradiated (b), treated with Poly-MVA (c) and treated with
irradiation (d) of the second mode of administration of poly-MVA (Group C) at different time intervals (1, 7 and 14 days).
j o u r n a l o f r a d i a t i o n r e s e a r c h and a p p l i e d s c i e n c e s 6 ( 2 0 1 3 ) 2 1e3 028The obtained results in this study agrees with the previ-
ously reported by Menon et al. (2009), who demonstrated that
the administration of poly-MVA for seven days prior to whole
body gamma radiation exposure (2.4 and 8 Gy) significantly
reduced the damage to cellular DNA in bone marrow and
blood leucocytes, as well as preventing the radiation induced
lowering of tissue antioxidant levels. The same author also
found that oral administration of the formulation to mice for
15 days showed an increase in GSH and glutathione peroxi-
dase (GPx) levels and decrease in MDA level in the kidney and
liver. At the same time the oral administration of POLY-MVA
to mice prior to whole body radiation (8 Gy) exposure offered
protection to cellular DNA as revealed by Comet assay of bone
marrow cells and peripheral blood of the irradiated mice.
Furthermore, Sudheesh, Ajith, Janardhanan, and Krishnan
(2010) concluded that the POLY-MVA significantly enhancethe activities of Krebs cycle dehydrogenases and respiratory
complexes in the heart of aged rat. It also enhanced the ac-
tivity of catalase, manganeseesuperoxide dismutase, gluta-
thione peroxidase, and the level of lipid peroxidation was
decreased significantly compared to the aged control.5. Conclusion
Poly-MVA provide a satisfied radio-prophylactic effect, as it
enhances the level of antioxidant enzymes and helps in
reducing the radiation induced abnormalities in red blood
cell morphology in both treated groups (before and contin-
uous administration with radiation exposure). However
administration before and after irradiation showed better re-
sults than administration before only. These results propose
j o u rn a l o f r a d i a t i o n r e s e a r c h and a p p l i e d s c i e n c e s 6 ( 2 0 1 3 ) 2 1e3 0 29useful application for planned radiation exposure during
diagnosis and radiotherapy. Continuous administration of
poly-MVA shows a better radio-prophylactic effect.Acknowledgement
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